Kim Ace S&P Asia Top50 ETF logo

Kim Ace S&P Asia Top50 ETF (277540)

Market Open
11 Aug, 06:30
KRX SM KRX SM
31,615. 00
+335
+1.071%
- Market Cap
- Div Yield
2,951 Volume
31,280
Previous Close
Add Transaction
Day Range
30,855 32,935
Year Range
19,365 40,000
Want to track 277540 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

277540 trading today higher at ₩31,615, an increase of 1.071% from yesterday's close, completing a monthly decrease of -14.7958% or -₩5,490. Over the past 12 months, 277540 stock gained 34.5319%.
277540 pays dividends to its shareholders, with the most recent payment made on Jan 05, 2026. The next estimated payment will be in 7 months ago on Jan 05, 2026 for a total of ₩666.
The stock of the company had never split.
The company's stock is traded on one exchange.

277540 Chart

Kim Ace S&P Asia Top50 ETF (277540) FAQ

What is the stock price today?

The current price is ₩31,615.00.

On which exchange is it traded?

Kim Ace S&P Asia Top50 ETF is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 277540.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Kim Ace S&P Asia Top50 ETF ever had a stock split?

No, there has never been a stock split.

Kim Ace S&P Asia Top50 ETF Profile

KRX SM Exchange
US Country

Overview

Invizyne Technologies, Inc. is a synthetic biochemical company based in the United States, with its headquarters located in Monrovia, California. Founded in 2014, the company has been at the forefront of developing innovative platforms for the production of a wide range of chemicals. These include pharmaceuticals, fuels, materials, food additives, and novel compounds. Invizyne Technologies leverages advanced biocatalytic conversion processes, utilizing one or more enzymes in modules to achieve desired chemical transformations. This innovative approach allows for more efficient and environmentally friendly production methods compared to traditional chemical synthesis.

Products and Services

  • SimplePath Platform

    The SimplePath platform is Invizyne Technologies' flagship technology, designed to produce a diverse array of chemicals. This platform distinguishes itself by utilizing modular biocatalytic conversion processes. Each module within the platform consists of one or more enzymes that work synergistically to convert substrates into desired products. This approach facilitates the efficient production of pharmaceuticals, fuels, materials, food additives, and novel compounds, showcasing the company's versatility and innovation in the biochemical sector.

Contact Information

Address: 750 Royal Oaks Drive, Monrovia, CA, United States, 91016
Phone: 626 415 1488